161 related articles for article (PubMed ID: 38298631)
1. Anti-enzymatic and DNA docking studies of montelukast: A multifaceted molecular scaffold with
Abdullah S; Iqbal A; Ashok AK; Kaouche FC; Aslam M; Hussain S; Rahman J; Hayat MM; Ashraf M
Heliyon; 2024 Jan; 10(2):e24470. PubMed ID: 38298631
[TBL] [Abstract][Full Text] [Related]
2. Identifying alkaline phosphatase inhibitory potential of cyclooxygenase-2 inhibitors: Insights from molecular docking, MD simulations, molecular expression analysis in MCF-7 breast cancer cell line and in vitro investigations.
Hussain S; Iqbal A; Hamid S; Putra PP; Ashraf M
Int J Biol Macromol; 2024 May; ():132721. PubMed ID: 38815949
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 2-amino-4,6-diarylpyrimidine derivatives as potent α-glucosidase and α-amylase inhibitors: structure-activity relationship,
Mughal EU; Amjid S; Sadiq A; Naeem N; Nazir Y; Alrafai HA; Hassan AA; Al-Nami SY; Abdel Hafez AA; Ali Shah SW; Ghias M
J Biomol Struct Dyn; 2024; 42(1):244-260. PubMed ID: 37096830
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Evaluation of 1,3,5-Triaryl-2-Pyrazoline Derivatives as Potent Dual Inhibitors of Urease and α-Glucosidase Together with Their Cytotoxic, Molecular Modeling and Drug-Likeness Studies.
Mehmood R; Sadiq A; Alsantali RI; Mughal EU; Alsharif MA; Naeem N; Javid A; Al-Rooqi MM; Chaudhry GE; Ahmed SA
ACS Omega; 2022 Feb; 7(4):3775-3795. PubMed ID: 35128286
[TBL] [Abstract][Full Text] [Related]
5. Three New Acrylic Acid Derivatives from
Farooq U; Khan S; Naz S; Wani TA; Bukhari SM; Aborode AT; Shahzad SA; Zargar S
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956953
[TBL] [Abstract][Full Text] [Related]
6. Antiurease Activity of Antibiotics: In Vitro, In Silico, Structure Activity Relationship, and MD Simulations of Cephalosporins and Fluoroquinolones.
Aslam M; Rahman J; Iqbal A; Mujtaba S; Ashok AK; Kaouche FC; Hayat MM; Nisa MU; Ashraf M
ACS Omega; 2024 Mar; 9(12):14005-14016. PubMed ID: 38559955
[No Abstract] [Full Text] [Related]
7. Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast.
Ramires R; Caiaffa MF; Tursi A; Haeggström JZ; Macchia L
Biochem Biophys Res Commun; 2004 Nov; 324(2):815-21. PubMed ID: 15474500
[TBL] [Abstract][Full Text] [Related]
8. The Synthesis, In Vitro Bio-Evaluation, and In Silico Molecular Docking Studies of Pyrazoline-Thiazole Hybrid Analogues as Promising Anti-α-Glucosidase and Anti-Urease Agents.
Khan Y; Khan S; Hussain R; Maalik A; Rehman W; Attwa MW; Masood R; Darwish HW; Ghabbour HA
Pharmaceuticals (Basel); 2023 Nov; 16(12):. PubMed ID: 38139777
[TBL] [Abstract][Full Text] [Related]
9. In vitro, in vivo and in silico anti-hyperglycemic inhibition by sinigrin.
Abbas Q; Hassan M; Raza H; Kim SJ; Chung KW; Kim GH; Seo SY
Asian Pac J Trop Med; 2017 Apr; 10(4):372-379. PubMed ID: 28552107
[TBL] [Abstract][Full Text] [Related]
10. Bioactive stigmastadienone from Isodon rugosus as potential anticholinesterase, α-glucosidase and COX/LOX inhibitor: In-vitro and molecular docking studies.
Alqahtani YS
Steroids; 2021 Aug; 172():108857. PubMed ID: 33945799
[TBL] [Abstract][Full Text] [Related]
11. In-vitro high-throughput library screening-Kinetics and molecular docking studies of potent inhibitors of α-glucosidase.
Ali M; Malik K; Zaidi A; Farooq U; Bukhari SM; Majeed Z; Mahnashi MH; Nawazish S; Abdulwahab A; Alshaibari KS
PLoS One; 2023; 18(6):e0286159. PubMed ID: 37390110
[TBL] [Abstract][Full Text] [Related]
12. The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies.
Durdagi S; Avsar T; Orhan MD; Serhatli M; Balcioglu BK; Ozturk HU; Kayabolen A; Cetin Y; Aydinlik S; Bagci-Onder T; Tekin S; Demirci H; Guzel M; Akdemir A; Calis S; Oktay L; Tolu I; Butun YE; Erdemoglu E; Olkan A; Tokay N; Işık Ş; Ozcan A; Acar E; Buyukkilic S; Yumak Y
Mol Ther; 2022 Feb; 30(2):963-974. PubMed ID: 34678509
[TBL] [Abstract][Full Text] [Related]
13. Jack Bean Urease Inhibitors, and Antioxidant Activity Based on Palmitic acid Derived 1-acyl-3- Arylthioureas: Synthesis, Kinetic Mechanism and Molecular Docking Studies.
Saeed A; Ur-Rehman S; Channar PA; Larik FA; Abbas Q; Hassan M; Raza H; Seo SY
Drug Res (Stuttg); 2017 Oct; 67(10):596-605. PubMed ID: 28672409
[TBL] [Abstract][Full Text] [Related]
14. 2-Benzylidenebenzofuran-3(2
Ashraf J; Mughal EU; Alsantali RI; Sadiq A; Jassas RS; Naeem N; Ashraf Z; Nazir Y; Zafar MN; Mumtaz A; Mirzaei M; Saberi S; Ahmed SA
RSC Adv; 2021 Oct; 11(56):35077-35092. PubMed ID: 35493176
[TBL] [Abstract][Full Text] [Related]
15. Iminothiazoline-Sulfonamide Hybrids as Jack Bean Urease Inhibitors; Synthesis, Kinetic Mechanism and Computational Molecular Modeling.
Saeed A; Mahmood SU; Rafiq M; Ashraf Z; Jabeen F; Seo SY
Chem Biol Drug Des; 2016 Mar; 87(3):434-43. PubMed ID: 26496515
[TBL] [Abstract][Full Text] [Related]
16. In Vitro α-Glucosidase and α-Amylase Inhibition, Cytotoxicity and Free Radical Scavenging Profiling of the 6-Halogeno and Mixed 6,8-Dihalogenated 2-Aryl-4-methyl-1,2-dihydroquinazoline 3-Oxides.
Magwaza NM; More GK; Gildenhuys S; Mphahlele MJ
Antioxidants (Basel); 2023 Nov; 12(11):. PubMed ID: 38001824
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
[TBL] [Abstract][Full Text] [Related]
18. Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations.
Rashid RSM; Temurlu S; Abourajab A; Karsili P; Dinleyici M; Al-Khateeb B; Icil H
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111312
[TBL] [Abstract][Full Text] [Related]
19. Utilizing the drug repurposing strategy on current drugs: new leads for peptic ulcers
Khan M; Nizamani A; Shah L; Ullah I; Waqas M; Halim SA; Ataya FS; Elgazzar AM; Batiha GE; Khan A; Al-Harrasi A
J Biomol Struct Dyn; 2024 Jan; ():1-14. PubMed ID: 38225797
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of Pueraria lobata root and its constituents.
Seong SH; Roy A; Jung HA; Jung HJ; Choi JS
J Ethnopharmacol; 2016 Dec; 194():706-716. PubMed ID: 27769948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
